National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 436684

Case Details

VAERS ID: 436684 (history)  
Form: Version 1.0  
Gender: Female  
Location: Unknown  
Submitted: 2011-10-03
Entered: 2011-10-04
   Days after submission:1
Vaccin­ation / Manu­facturer Lot / Dose Site / Route

Administered by: Other       Purchased by: Other
Symptoms: Bedridden, Biopsy, Blood aluminium increased, Blood test, Carbohydrate intolerance, Coeliac disease, Glucose tolerance impaired, Hypoaesthesia, Lumbar puncture, Mobility decreased, Reaction to preservatives, Toxicologic test abnormal, Vomiting, Weight decreased
SMQs:, Acute pancreatitis (broad), Peripheral neuropathy (broad), Hyperglycaemia/new onset diabetes mellitus (narrow), Parkinson-like events (broad), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Lipodystrophy (broad), Hypersensitivity (narrow), Tendinopathies and ligament disorders (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? No
ER Visit? Yes
ER or Doctor Visit? No
Hospitalized? Yes, 17 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Unknown
Diagnostic Lab Data: Unknown
CDC Split Type: WAES1109USA02730

Write-up: Information has been received from a consumer concerning her daughter, who on an unspecified date was vaccinated with a first dose of GARDASIL (lot #, dose and route not reported). The mother reported that on an unspecified date her daughter experienced vomiting within 12 hours of receiving her first dose of the vaccine. The vomiting had not stopped since then. The consumer reported that her daughter had 90% of the post-marketing side effects in the prescribing information. On an unspecified date her daughter experienced a 30 pound weight loss and could no longer eat anything with gluten, sugar, preservatives or carbohydrates. She was starting to experience numbness in both feet. At some unidentified time her daughter was in bed for 5 months. She also reported that her daughter had a toxic level of aluminum in her system. She was hospitalized for 17 days; lab diagnostic studies included biopsy, spinal taps and unspecified blood tests (results not provided). At the time of the report the patient had not recovered from the adverse events. Vomiting, weight loss, could not eat anything with gluten, sugar, preservatives or carbohydrates, numbness in her feet, was in bed for 5 months and toxic level of aluminum were considered to be disabling and immediately life-threatening. This is one of several reports received from the same source. Additional information is not expected.

New Search

Link To This Search Result:

Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166